(Reuters) - Atrium said the purchase of the German drug maker will
immediately boost its earnings per share by about 45 percent.
Read more at Reuters.com Mergers News
immediately boost its earnings per share by about 45 percent.
Read more at Reuters.com Mergers News
No comments:
Post a Comment